Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses JR Barrett, S Belij-Rammerstorfer, C Dold, KJ Ewer, PM Folegatti, ... Nature medicine 27 (2), 279-288, 2021 | 335 | 2021 |
Structural basis for iron piracy by pathogenic Neisseria N Noinaj, NC Easley, M Oke, N Mizuno, J Gumbart, E Boura, AN Steere, ... Nature 483 (7387), 53-58, 2012 | 295 | 2012 |
Periplasmic superoxide dismutase in meningococcal pathogenicity KE Wilks, KLR Dunn, JL Farrant, KM Reddin, AR Gorringe, PR Langford, ... Infection and immunity 66 (1), 213-217, 1998 | 150 | 1998 |
Bexsero: a multicomponent vaccine for prevention of meningococcal disease AR Gorringe, R Pajón Human vaccines & immunotherapeutics 8 (2), 174-183, 2012 | 145 | 2012 |
Neisseria lactamica Protects against Experimental Meningococcal Infection KJ Oliver, KM Reddin, P Bracegirdle, MJ Hudson, R Borrow, IM Feavers, ... Infection and immunity 70 (7), 3621-3626, 2002 | 143 | 2002 |
Nasal Inoculation of the Commensal Neisseria lactamica Inhibits Carriage of Neisseria meningitidis by Young Adults: A Controlled Human Infection Study AM Deasy, E Guccione, AP Dale, N Andrews, CM Evans, JS Bennett, ... Clinical infectious diseases 60 (10), 1512-1520, 2015 | 139 | 2015 |
Recombinant Neisseria meningitidis Transferrin Binding Protein A Protects against Experimental Meningococcal Infection D West, K Reddin, M Matheson, R Heath, S Funnell, M Hudson, ... Infection and immunity 69 (3), 1561-1567, 2001 | 139 | 2001 |
Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design DA Ala'Aldeen, P Stevenson, E Griffiths, AR Gorringe, LI Irons, ... Infection and immunity 62 (7), 2984-2990, 1994 | 127 | 1994 |
Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model FG Mackinnon, R Borrow, AR Gorringe, AJ Fox, DM Jones, A Robinson Microbial pathogenesis 15 (5), 359-366, 1993 | 115 | 1993 |
Genomic analysis of isolates from the United Kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving KL Sealey, SR Harris, NK Fry, LD Hurst, AR Gorringe, J Parkhill, ... The Journal of infectious diseases 212 (2), 294-301, 2015 | 110 | 2015 |
Nasopharyngeal Colonization by Neisseria lactamica and Induction of Protective Immunity against Neisseria meningitidis CM Evans, CB Pratt, M Matheson, TE Vaughan, J Findlow, R Borrow, ... Clinical Infectious Diseases 52 (1), 70-77, 2011 | 105 | 2011 |
Neisserial Outer Membrane Vesicles Bind the Coinhibitory Receptor Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 1 and Suppress CD4+ T … HSW Lee, IC Boulton, K Reddin, H Wong, D Halliwell, O Mandelboim, ... Infection and immunity 75 (9), 4449-4455, 2007 | 92 | 2007 |
Acquisition and loss of virulence-associated factors during genome evolution and speciation in three clades of Bordetella species B Linz, YV Ivanov, A Preston, L Brinkac, J Parkhill, M Kim, SR Harris, ... BMC genomics 17, 1-17, 2016 | 89 | 2016 |
Risk factors for Group B Streptococcus colonisation and disease in Gambian women and their infants K Le Doare, S Jarju, S Darboe, F Warburton, A Gorringe, PT Heath, ... Journal of Infection 72 (3), 283-294, 2016 | 86 | 2016 |
Phase I Safety and Immunogenicity Study of a Candidate Meningococcal Disease Vaccine Based on Neisseria lactamica Outer Membrane Vesicles AR Gorringe, S Taylor, C Brookes, M Matheson, M Finney, M Kerr, ... Clinical and vaccine immunology 16 (8), 1113-1120, 2009 | 85 | 2009 |
Serospecific protection of mice against intranasal infection with Bordetella pertussis A Robinson, AR Gorringe, SGP Funnell, M Fernandez Vaccine 7 (4), 321-324, 1989 | 81 | 1989 |
Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the … J Findlow, S Taylor, A Aase, R Horton, R Heyderman, J Southern, ... Infection and immunity 74 (8), 4557-4565, 2006 | 71 | 2006 |
The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles A Gorringe, D Halliwell, M Matheson, K Reddin, M Finney, M Hudson Vaccine 23 (17-18), 2210-2213, 2005 | 70 | 2005 |
Generation and characterization of a PhoP homologue mutant of Neisseria meningitidis CR Johnson, J Newcombe, S Thorne, HA Borde, LJ Eales‐Reynolds, ... Molecular microbiology 39 (5), 1345-1355, 2001 | 68 | 2001 |
Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens TE Vaughan, PJ Skipp, CD O’Connor, MJ Hudson, R Vipond, MJ Elmore, ... Vaccine 24 (25), 5277-5293, 2006 | 67 | 2006 |